Evaluation and Treatment of Diabetic Neuroarthropathy - Medical ...
Evaluation and Treatment of Diabetic Neuroarthropathy - Medical ... Evaluation and Treatment of Diabetic Neuroarthropathy - Medical ...
Amputation Epidemiology #1 cause nontraumatic amputations > 60% in diabetics 2006: 65,700 L.E.A. in diabetics 2 yr. mortality BKA: 36% AKA: > 50% National Diabetes Fact Sheet http://www.cdc.gov/diabetes
- Page 26: Mechanical, structural factors •
- Page 30 and 31: Sensation Monofilament testing 5.07
- Page 32 and 33: Circulation Waveform characteristic
- Page 34 and 35: Infection • screening labs CBC, E
- Page 36 and 37: Infection
- Page 38 and 39: Healing potential Screening labs to
- Page 40 and 41: Off-loading • pressure prevents u
- Page 42 and 43: Total contact cast
- Page 44 and 45: Protection
- Page 46 and 47: Exostectomy
- Page 48 and 49: Exostectomy
- Page 50 and 51: Reconstruction
- Page 52 and 53: Neuroarthropathy • Jean-Martin Ch
- Page 54 and 55: Neuroarthropathy Typical scenario i
- Page 58 and 59: Neuroarthropathy • “no ulcer -
- Page 60 and 61: Neuroarthropathy “at-risk” fact
- Page 62 and 63: Etiology Neurovascular theory neura
- Page 64: stage I Charcot • x-ray: fragment
- Page 67 and 68: stage III Charcot • x-ray: recons
- Page 69 and 70: Neuroarthropathy Treatment goals cr
- Page 71 and 72: Charcot acute treatment • strict
- Page 73 and 74: Stage II treatment • protected we
- Page 76: Surgical indications • gross inst
- Page 83 and 84: Diabetic salvage failure • poor c
- Page 86 and 87: Conclusions Neuropathy treatment mo
- Page 88 and 89: Conclusions Ulcer treatment infecti
- Page 90 and 91: Conclusions Charcot treatment recog
- Page 92: Primary Care Foot Program Jessica A
Amputation<br />
Epidemiology<br />
#1 cause nontraumatic amputations<br />
> 60% in diabetics<br />
2006: 65,700 L.E.A. in diabetics<br />
2 yr. mortality<br />
BKA: 36%<br />
AKA: > 50%<br />
National Diabetes Fact Sheet<br />
http://www.cdc.gov/diabetes
Change language